Coronavirus Update: Pfizer/BioNTech Commit 500m Doses For US Donations

Pfizer Inc. and BioNTech SEsaid on 10 June that they will sell 500 million doses of their COVID-19 vaccine to the US government at non-profit prices for donation to approximately 100 lower-income and lower-middle-income countries, including African nations covered under the COVAX initiative. This agreement is part of the two companies’ pledge of two billion doses to support equitable global access to COVID-19 vaccines.

On 2 June, the COVAX Advance Market Commitment announced that it had raised an additional $2.4bn for its efforts, bringing...